054-3 Wyo. Code R. § 3-3

Current through April 27, 2019
Section 3-3 - Scope and Standards of Nursing Practice for the APRN

(a) Scope and Standards for APRN:

  • (i) The APRN is subject at all times to the standards and scope of practice established by national professional organizations and/or accrediting agencies representing the various core, role and population focus areas for APRNs, and the NPA.
  • (ii) The Board recognizes APRN core, role and population focus areas described in the scope of practice statements for APRNs issued by national professional organizations and/or accrediting agencies.
  • (iii) Role and population focus of the APRN shall be declared upon application for licensure, and the role and population focus to be utilized shall be the title(s) granted by nationally recognized professional organization(s) and/or accrediting agency(ies) or the title(s) of the role and population focus of nursing practice in which the APRN has received postgraduate education preparation.
  • (iv) In order to practice in one of the four roles and in a defined population, the APRN shall be recognized by the Board in that particular role with a population focus of advanced practice nursing.

(b) Prescriptive Authority:

  • (i) The Board may authorize an APRN to prescribe, order, procure, administer, dispense and furnish over the counter, legend and controlled substances pursuant to applicable state and federal laws and within the APRN's role and population focus.
  • (ii) Authorized prescriptions by an APRN shall:
    • (A) Comply with all current applicable state and federal laws; and
    • (B) Be signed by the APRN with the initials "APRN" or the initials of the nationally recognized role and population focus.
  • (iii) APRNs may receive, sign for, record, and distribute samples to clients. Distribution of drug samples shall be in accordance with state law and Drug Enforcement Agency laws, regulations, and guidelines.
  • (iv) The Board shall transmit to the Board of Pharmacy a list of all APRNs who have prescriptive authority. The list shall include:
    • (A) The name of the authorized APRN;
    • (B) The RN license number, role and population focus of the APRN recognized by the Board; and
    • (C) The effective date of prescriptive authority authorization.
  • (v) The Board will notify the Board of Pharmacy within two working days after termination of or change in the prescriptive authority of an APRN.

(c) Applicability:

  • (i) The provisions of this chapter are only applicable to an APRN who is recognized as an APRN, who is authorized to perform advanced and specialized acts of nursing practice, advanced nursing and medical diagnosis, and the administration and prescription of therapeutic and corrective measures comes from educational preparation, national certification, and recognition to practice in compliance with Board Rules.
  • (ii) Nothing in this chapter prohibits the usual and customary practice of an APRN in the State from directly administering prescribed controlled substances under derived authority. In addition, the direct administration, or the ordering of controlled substances preoperatively, intraoperatively or postoperatively, by an APRN (certified registered nurse anesthetist) does not involve prescribing within the meaning of 21 CFR 1308.02(f) or the Board Rules. These rules do not require any changes in the current practice and procedures of APRN, who are certified registered nurse anesthetists or the institutional and individual practitioners with whom they may practice.
  • (iii) Nothing in this section limits or enhances the usual and customary practice of an RN or LPN in the State.

054-3 Wyo. Code R. § 3-3

Amended, Eff. 9/7/2017.